Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Clinical trial NCT01251133 · COMPLETED

Trial details

NCT number: NCT01251133
Sponsor: LG Life Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infectious Disease by Haemophilus Influenzae Type b

Start date: 2008-07-01
Primary completion: 2009-03-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.